Feed aggregator
PRGO CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Perrigo Company plc Shareholders
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned French v. Perrigo Company plc, et al., Case No. 1:25-cv-09596, on behalf of persons and entities that purchased or otherwise acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). Plain
White Paper on Leadership Opportunities for AI to Increase Employee Value Released by University of Phoenix College of Doctoral Studies
PHOENIX--(BUSINESS WIRE)--University of Phoenix College of Doctoral Studies announces a new white paper, “Leadership Opportunities for Increasing Employee Value through Artificial Intelligence,” authored by Andrew C. Lawlor, PhD, and Pamayla E. Darbyshire, DHA, MSN/CNS, both Fellows at the Center for Educational and Instructional Technology Research (CEITR). The paper examines how leaders can use AI, especially generative AI, to address skills gaps, restore worker autonomy, and shift employees
Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy
LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm’s disciplined, science-first approach to company building and investing. Earlier today, Halda Therapeutics announced its acquisition by Johnson & Johnson (NYSE: JNJ) for $3.05 billion, marking a historic moment for the Vida III portfolio. Hald
